Urokinase CAS 9039-53-6 C21H25BrN2O3 Pharmaceutical Grade Chemicals

Basic Information
Place of Origin: CHINA
Brand Name: MOSINTER
Certification: COA
Model Number: Circulatory System Drugs API - 5
Minimum Order Quantity: 1KG
Price: Negotiation
Packaging Details: Aluminum foil bag , kraft paper bag
Delivery Time: Within 7 days
Payment Terms: L/C, T/T
Supply Ability: Can be customized according to customer requirements
Detail Information
Name: Urokinase CAS: 9039-53-6
Form: Powder Molecular Formula: C21H25BrN2O3
Water: ≤1.0% Color: White
High Light:

pharmaceutical raw materials


raw material for medicine manufacturing

Product Description

Urokinase CAS 9039-53-6 C21H25BrN2O3 Pharmaceutical Grade Chemicals

 This product is an enzyme protein isolated from the urine of healthy people or obtained from human kidney tissue culture.It is composed of molecular weights of 33000 (mw - tcu-pa) and 54000 (mw - tcu-pa).This product direct effects on endogenous fibrinolysis system, which can catalytic cracking fibrinolytic enzyme into a fibrinolytic enzyme, which can not only degradation of fibrin clot, also can degrade fibrinogen in blood, and clotting factor Ⅴ and blood coagulation factor Ⅷ etc, so as to play a role of thrombolysis.




Test Results


A.H-NMR:Comply with the structure


B.LC-MS:Comply with the structure


C.The IR spectrum of sample should be identical with that of reference standard;




The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.


meets the requirements.


Loss on drying



Heavy metals

≤10 ppm





Sulphated ash

≤0.5%, determined on 1.0 g.


Related substances

Unspecified impurities: for each impurity



Total Impurity







99.0%~101.0% (anhydrous substance).




This product is mainly used for thrombolytic therapy of thromboembolic diseases.These included acute generalized pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other peripheral artery embolism with severe iliac - femoral vein thrombosis.It is also used to prevent thrombosis after the operation of artificial heart valve, and to keep vascular intubation and drainage tube of chest cavity and pericardium unobstructed.The efficacy of thrombolytic therapy should be maintained by subsequent heparin anticoagulation.

This product is an enzymatic thrombolytic drug, which can activate the conversion of plasminogen into plasminogen in vivo, and hydrolyze fibrin to dissolve the freshly formed thrombus.Used for acute myocardial infarction, acute cerebral thrombosis and cerebrovascular embolism, perilimb arteriovenous thrombosis, central retinal arteriovenous thrombosis and other fresh thrombosis occlusive diseases.This product has no obvious effect on old thrombus.It is also suitable for the treatment of fresh thromboembolic diseases such as cerebral thrombosis, peripheral vascular embolism, central retinal vascular embolism, acute myocardial infarction, as well as renal transplantation, plastic surgery and other thrombosis, all of which have good curative effect.

Our strengths:
We can customize according to customer's requirement.
If you have any question pls mail us or call us.



Contact Details

Phone Number : +86 18989305995

WhatsApp : +18989305995